Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AARTIDRUGS Stock Analysis
Views
Red Flags
Positive
Stock is reasonably valued and PE TTM is at a discount to industry median
Analysts have been raising forward EPS estimates
Strong EPS growth and above median growth of industry
Low Debt to Equity, not much change from last year
Consistently pays dividend
Negative
Low but stable operating margin
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate and stable ROE
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
AARTIDRUGS Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AARTIDRUGS Bulk, Block & Insider Trades
AARTIDRUGS Dividends, Splits & Bonus
Dividend Events
Capital Change Events
Bonus
Others
Bonus(3 new shares for 1 existing shares) Ex-date: 30th Sep 2020 Announced on: 20th Aug 2020
Bonus(1 new shares for 1 existing shares) Ex-date: 24th Mar 2015 Announced on: 30th Jan 2015
Bonus(1 new shares for 2 existing shares) Ex-date: 13th May 1996 Announced on: 15th Jan 1996
Share Buyback"On Market tender offer.Open Market Purchase. As of 26 September 2024Shares Repurchased 665000. Total Amount Returned INR 598500000. Share capital 0.72 percent Currently." Ex-date: 5th Sep 2024 Announced on: 26th Sep 2024
Share Buyback"On Market Tender Offer. Total Amount Returned INR 598500000. As of 01 September 2023 Shares repurchased 665000." Ex-date: 4th Aug 2023 Announced on: 21st Jul 2023
Share BuybackOn market tender offer. Ex-date: 30th Mar 2021 Announced on: 19th Mar 2021
Share Buyback"On Market Tender Offer. Total Amount Returned INR 253890000 . Share Capital 1.20 percent currently." Ex-date: 28th Mar 2019 Announced on: 15th Mar 2019
Share BuybackOn Market Tender Offer. Total Amount returned INR 240625000. Share capital 1.15% currently. Ex-date: 18th Jan 2018 Announced on: 8th Jan 2018
Company Profile
Aarti Drugs Limited is an India-based company, which is engaged in the manufacturing of active pharmaceutical ingredients (APIs), pharma intermediates, specialty chemicals and formulations. The Company operates in the pharmaceuticals segment. Its geographical segments include Out of India and India.... Read More
Key personnel
Shri. Prakash M. PatilD
Chairman of the Board, Chief Executive Officer, Managing Director, Executive Director
Shri. Chandrakant Vallabhaji GogriD
Chairman Emeritus
Shri. Adhish P. Patil
Chief Financial Officer, Chief Operating Officer
Mr. Rushikesh Vivek Deole
Compliance Officer, Company Secretary
Shri. Harshit Manilal SavlaD
Joint Managing Director, Executive Director
Shri. Rashesh Chandrakan GogriD
Managing Director, Executive Director
Shri. Uday Moreshwar PatilD
Executive Director
Shri. Harit Pragji ShahD
Executive Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Aarti Drugs Ltd.?
The current share price of Aarti Drugs Ltd. is ₹ 384.93 as of 09 Jan 2026.
What is the PE ratio of Aarti Drugs Ltd.?
The Price-to-Earnings (PE) ratio of Aarti Drugs Ltd. is 17.66 as of the latest financial data.
What is the ROE and ROCE of Aarti Drugs Ltd.?
Aarti Drugs Ltd. has a Return on Equity (ROE) of 12.69% and a Return on Capital Employed (ROCE) of 12.08% as per the latest financial reports.
What is the market cap of Aarti Drugs Ltd.?
The market capitalization of Aarti Drugs Ltd. stands at ₹ 3,513.26 Cr.
What is the dividend yield of Aarti Drugs Ltd.?
The dividend yield of Aarti Drugs Ltd. is 0.26% based on the current market price.
What is the RSI of Aarti Drugs Ltd.?
The Relative Strength Index (RSI) of Aarti Drugs Ltd. is 34.64.
What is the FII and DII holding in Aarti Drugs Ltd.?
Foreign Institutional Investors (FII) hold 2.68% and Domestic Institutional Investors (DII) hold 9.89% of Aarti Drugs Ltd. shares.
What sector does Aarti Drugs Ltd. belong to?
Aarti Drugs Ltd. operates in the Healthcare sector.
What is the beta of Aarti Drugs Ltd. stock?
The beta of Aarti Drugs Ltd. stock is 1.10, indicating its volatility relative to the broader market.
